Department of Hematology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey.
Department of Nephrology, University of Celal Bayar, Manisa, Turkey.
Support Care Cancer. 2021 Jul;29(7):4089-4094. doi: 10.1007/s00520-020-05924-w. Epub 2021 Jan 6.
Febrile neutropenia (FN) is a hematological emergency. It is challenging and confusing for the clinicians to make the decision of the febrile neutropenic patients under chemotherapy to be monitored at intensive care unit (ICU). The aim of this study was to define the factors supporting decision-making for the critical patients with febrile neutropenia.
The data of 60 patients, who were taken to the ICU while they were under treatment in the Hematology Clinic with a diagnosis of febrile neutropenia, were analyzed retrospectively, in order to identify clinically useful prognostic parameters.
The ICU mortality rate was 80%. Mortality was significantly associated with higher sequential organ failure assessment score (SOFA), quick sequential organ failure assessment score (qSOFA), and hematological SOFA (SOFAhem) scores on admission. All cases having SOFA score 10 and above and qSOFA score 2 and above died. In multivariate analysis, qSOFA score was found to be statistically significant in predicting mortality in regard to ICU admission (p = 0.004).
Mortality of febrile neutropenic patients admitted to ICU is high. It would be appropriate to determine the extent of organ dysfunction instead of underlying disease, for making the decision of ICU admission. It should be noticed that the risk mortality is high for the FN cases with SOFA score 10 or above, qSOFA score 2 or above, and in need of mechanical ventilation and positive inotropic support; hence, early intervention is recommended. In our study, the most significant parameter in predicting ICU mortality was found to be qSOFA.
发热性中性粒细胞减少症(FN)是一种血液学急症。对于临床医生来说,决定接受化疗的发热性中性粒细胞减少症患者是否需要在重症监护病房(ICU)进行监测是具有挑战性和困惑性的。本研究的目的是确定支持对危重症发热性中性粒细胞减少症患者进行决策的因素。
回顾性分析了 60 例在血液科接受治疗时因发热性中性粒细胞减少症而被送入 ICU 的患者的数据,以确定具有临床意义的预后参数。
ICU 死亡率为 80%。死亡率与较高的序贯器官衰竭评估评分(SOFA)、快速序贯器官衰竭评估评分(qSOFA)和入院时的血液学 SOFA(SOFAhem)评分显著相关。所有 SOFA 评分≥10 分和 qSOFA 评分≥2 分的患者均死亡。多变量分析发现,qSOFA 评分是 ICU 入院时预测死亡率的统计学显著因素(p=0.004)。
入住 ICU 的发热性中性粒细胞减少症患者的死亡率较高。确定器官功能障碍的程度而不是潜在疾病,可能更适合用于决定 ICU 入院。应当注意,SOFA 评分≥10 分、qSOFA 评分≥2 分、需要机械通气和正性肌力支持的 FN 病例,其死亡风险较高,因此建议早期干预。在本研究中,预测 ICU 死亡率的最显著参数是 qSOFA。